Investor Presentation
AI summary
- Q1 FY27 revenue 1,076.2 mn +71% y-y; EBITDA 392.5 mn +98% y-y; EBITDA margin 36.5% +5% y-y; PAT 278.6 mn +46% y-y
- Signed long-term supply agreement with aerospace Tier-1 FACC; Hobel Bellows acquisition consolidated from May 2026
- Order book strong at 2,803 mn including 873 mn nuclear order; pipeline includes aerospace and semiconductor Tier-1 LTAs
- Capacity utilisation expected to improve as qualification programs move to serial production in FY27
- Strategic focus on qualification-led growth, expanding aerospace tooling and precision components businesses
- Kanoo JV in Saudi Arabia supports regional oil & gas manufacturing; Hobel Bellows acquisition expands precision engineering capabilities
- Management confident FY27 will deliver strong growth and value creation on a global precision engineering platform
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 UNIMECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add UNIMECH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Unimech Aerospace and Manufacturing Limited
Important.
The summary above is generated automatically from Unimech Aerospace and Manufacturing Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.